BSD Medical Announces Publication of Study Showing Hyperthermia Increases Effectiveness of Other Cancer Treatments by Preventing Repair of Tumor Cells

BSD Medical Corporation BSDM announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy. The researchers reported that the findings have the potential to significantly increase the clinical use of hyperthermia. The study (Krawczyk, PM, et al., "Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly [ADP-ribose] polymerase-1 inhibition," PNAS, doi: 10.1073/pnas.1101053108, 2011) was reviewed in The Scientist (http://www.the-scientist.com/news/display/58165/). Roland Kanaar, one of the researchers, summarized the study results for The Scientist, "The finding may have immediate applications in cancer therapeutics. It's simple, but it has big implications."